Hereditary colorectal cancer syndromes: diagnostic approach and management

被引:0
|
作者
Aretz, Stefan [1 ,2 ]
Steinke-Lange, Verena [3 ,4 ]
Vilz, Tim O. [2 ,5 ]
Raedle, Jochen [6 ]
机构
[1] Univ Klinikum Bonn, Inst Humangenet, Venusberg Campus 1, D-53127 Bonn, Germany
[2] Univ Klinikum Bonn, Natl Zentrum Erbl Tumorerkrankungen, Bonn, Germany
[3] Med Genet Zentrum MGZ, Munich, Germany
[4] Klinikum Univ Munchen, Med Klin & Poliklin 4, Campus Innenstadt, Munich, Germany
[5] Univ Klinikum Bonn, Klin & Poliklin Allgemein Viszeral Thorax & Gefas, Bonn, Germany
[6] Westpfalz Klinikum GmbH, Standort Kaiserslautern 1, Klin Innere Med 3, Kaiserslautern, Germany
来源
ONKOLOGE | 2021年 / 27卷 / 03期
关键词
Familial colorectal cancer; Tumor predisposition syndromes; Lynch syndrome; Polyposis syndrome; Surveillance; Prophylactic surgery; LYNCH-SYNDROME; GASTROINTESTINAL CANCER; BETHESDA GUIDELINES; POLYPOSIS; RISK; RECOMMENDATIONS; SOCIETY; SURVEILLANCE; INDIVIDUALS; VARIANTS;
D O I
10.1007/s00761-020-00884-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer (CRC) is the third most common cancer among men and women in Germany. Between 3 and 5% of all CRC cases are attributed to a well-defined inherited tumor predisposition syndrome (hereditary CRC). Materials and methods A summary of a selective literature search and our own work concerning hereditary CRC and gastrointestinal polyposis syndromes is provided. Results Hereditary CRC includes Lynch syndrome/hereditary nonpolyposis colon cancer (HNPCC), familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), and various hamartomatous polyposis syndromes (Peutz-Jeghers syndrome, juvenile polyposis, Cowden syndrome). These syndromes are caused by various germline mutations, which are often associated with an autosomal dominant inheritance and an unusual individual and/or familial tumor history due to a significantly increased risk of colorectal and other cancers. The etiology of the serrated polyposis syndrome (SPS) is largely unknown so far. Conclusions Identification of individuals at risk and the detection of relevant mutations by appropriate genetic testing are crucial to offer affected individuals a lifelong surveillance strategy addressed to the individual cancer risk. In addition to a repetitive screening colonoscopy this may also include other preventive interventions. For some hereditary syndromes, prophylactic surgery is a very efficient option to reduce the tumor risk.
引用
收藏
页码:203 / 218
页数:16
相关论文
共 50 条
  • [1] Diagnostic Approach to Hereditary Colorectal Cancer Syndromes
    Kalady, Matthew F.
    Heald, Brandie
    CLINICS IN COLON AND RECTAL SURGERY, 2015, 28 (04) : 205 - 214
  • [2] Management of Colorectal Cancer in Hereditary Syndromes
    Cunningham, Lisa A.
    Gasior, Alessandra
    Kalady, Matthew F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2022, 31 (02) : 307 - 319
  • [3] Hereditary colorectal cancer syndromes: management and surveillance
    Aretz, S.
    Steinke-Lange, V
    Raedle, J.
    GASTROENTEROLOGE, 2020, 15 (04): : 259 - 272
  • [4] Clinical management of hereditary colorectal cancer syndromes
    Hans F. A. Vasen
    Ian Tomlinson
    Antoni Castells
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 : 88 - 97
  • [5] Clinical management of hereditary colorectal cancer syndromes
    Half, EE
    Bresalier, RS
    CURRENT OPINION IN GASTROENTEROLOGY, 2004, 20 (01) : 32 - 42
  • [6] Recognition and management of hereditary colorectal cancer syndromes
    Herraiz, M.
    Munoz-Navas, M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (02) : 125 - 132
  • [7] Clinical management of hereditary colorectal cancer syndromes
    Vasen, Hans F. A.
    Tomlinson, Ian
    Castells, Antoni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2015, 12 (02) : 88 - 97
  • [8] Clinical Management of Families with Hereditary Colorectal Cancer Syndromes
    Dandapani, Monica
    Stoffel, Elena M.
    SEMINARS IN COLON AND RECTAL SURGERY, 2011, 22 (02) : 100 - 104
  • [9] Clinical diagnosis and management of hereditary colorectal cancer syndromes
    Vasen, HFA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 81S - 92S
  • [10] The changing approach for identifying hereditary colorectal cancer syndromes
    Luigi Laghi
    Luigi Ricciardiello
    Nature Reviews Gastroenterology & Hepatology, 2020, 17 : 593 - 594